Authors |
Year |
Title |
Journal and link to the article |
Bespalov A, Michel M, Steckler T (eds) |
2020 |
Handbook of Experimental Pharmacology – Good Research Practice in Pharmacology/Experimental Life Sciences |
Springer |
Arroyo-Araujo et al. |
2019 |
Reproducibility via coordinated standardization: a multi-center study in a Shank2 genetic rat model for Autism Spectrum Disorders |
Scientific Reports |
Prager et al. |
2018 |
Improving transparency and scientific rigor in academic publishing |
Improving transparency and scientific rigor in academic publishing |
Bespalov et al. |
2018 |
Industry is more alarmed about reproducibility than academia |
Nature |
Bespalov & Steckler |
2018 |
Lacking quality in research: Is behavioral neuroscience affected more than other areas of biomedical science? |
Journal of Neuroscience Methods |
Kokras et al. |
2017 |
Kinoscope: An Open-Source Computer Program for Behavioral Pharmacologists. |
Frontiers in Behavioral Neuroscience |
Bespalov et al. |
2016 |
Failed clinical trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets. |
Nature Reviews Drug Discovery |
Popp et al. |
2016 |
In search of the mechanisms of ketamine’s antidepressant effects: How robust is the evidence behind the mTor activation hypothesis. |
F1000Research |
Steckler et al. |
2016 |
Reporting guidelines for Psychopharmacology |
Psychopharmacology |
Steckler et al. |
2015 |
The Preclinical Data Forum Network: A new ECNP initiative to improve data quality and robustness for (preclinical) neuroscience. |
European Neuropsychopharmacology |
Steckler |
2015 |
Preclinical data reproducibility for R&D – the challenge for neuroscience |
Psychopharmacology |